-
Mashup Score: 2Dr. Shore on what he's most looking forward to at AUA 2024 - 17 hour(s) ago
Neal D. Shore, MD, shares what he’s most looking forward to at this year’s American Urological Association Annual Meeting.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Expert discusses novel approach to ctDNA detection in MIBC - 21 hour(s) ago
“[This] shows a different approach for detecting circulating tumor DNA in bladder cancer patients, and it opens up the possibility for other biorepositories that have serum samples to also enter the ctDNA research environment,” says Richard T. Bryan, MBChB, PhD, MRCS, FacadTM.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 4
Investigators will begin setting up the TRANSFORM trial in spring 2024, with study recruitment set to begin later in the year
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Innovation fund to bolster adoption of prostate cancer test - 2 day(s) ago
The test, which was launched in Canada in September 2023, is available through Nanostics’ accredited laboratory in Edmonton, Alberta.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
“We felt that it was important to again address this topic because we have received numerous questions regarding the correct use of this code and we have had some experience using the code now that it is active and been able to observe some of the initial payment processing by the payer,” write Jonathan Rubenstein, MD, and Mark Painter.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 5
“Results from these trials show that giving physicians an alert informing them of their patient’s actual risk for antibiotic resistance can help them choose the best antibiotic and reduce extended-spectrum antibiotic use,” says Shruti Gohil, MD, MPH.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 7
“Ultimately, we found that in this retrospective evaluation, there was no significant difference in recurrence-free survival in those who are treated with gemcitabine and docetaxel as compared to BCG,” says Ryan L. Steinberg, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Study progresses of NK cell therapy in mCRPC - 2 day(s) ago
All patients have been successfully dosed in the first cohort of patients, and the Safety Review Committee has granted approval for progression of the study to the second dose level of INKmune.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Conference - 2 day(s) ago
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1
Jaideep S. Sohi, MD, shares his vision for the future of PSMA-PET imaging in prostate cancer.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Dr. Neal D. Shore shares what he's most looking forward to at this year's #AUA24 Annual Meeting. @AmerUrological #urology #urologist Watch now: https://t.co/X4zdOJscbq